No. | Characteristics | Length of Stay (n) |
|
---|---|---|---|
– | < 4 days |
≥4 days |
|
1 | Sex, n (%) | ||
Male | 11 (78.6%) | 49 (60.5%) | |
Female | 3 (21.4%) | 32 (39.5%) | |
2 | Mean age (SD) Months | 28.3 (31.6) | 27.0 (36.3) |
3 | Mean weight (SD), kg | 13.9 (14.0) | 11.9 (11.1) |
4 | Mean height (SD), cm | 76.3 (28.7) | 77.01 (27.9) |
5 | Nutritional status, n (%) | ||
Over Weight | 3 (21.4%) | 12 (14.8%) | |
Normal Weight | 5 (35.7%) | 39 (48.1%) | |
Underweight | 4 (28.6%) | 24 (29.6%) | |
Malnourished | 2 (14.3%) | 6 (7.4%) | |
6 | Primary Disease, n (%) | ||
Respiration | 8 (57.1%) | 45 (55.6%) | |
Cardiovascular | 0 (0%) | 3 (3.7%) | |
Infection | 1 (7.1%) | 12 (14.8%) | |
Hepatic/Gastrointestinal | 2 (14.3%) | 8 (9.9%) | |
Neurology | 0 (0%) | 2 (2.5%) | |
Hematology/Oncology | 0 (0%) | 3 (3.7%) | |
Immunology | 0 (0%) | 2 (2.5%) | |
Post Surgery | 1 (7.1%) | 4 (4.9%) | |
Metabolic | 2 (14.3%) | 2 (2.5%) | |
Others | 0 (0%) | 0 (0%) | |
7 | Mean WBC (SD), 103 μ/L | 10.9 (7.0) | 17.4 (12.7) |
8 | Mean Procalcitonin (SD), ng/ml | 10.4 (26.9) | 33.8 (55.7) |
9 | Mean CRP (SD), mg/l | 54.0(106.2) | 64.9 (91.6) |
10 | Comorbidity, n (%) | ||
Malignancy | 1 (7.1%) | 6 (7.4%) | |
HIV | 0 (0%) | 5 (6.2%) | |
None | 13 (92.9%) | 70 (86.4%) | |
12 | Mean duration of definitive antibiotic (SD), day | 4.1(4.7) | 4.1(4.7) |
13 | Mean length of stay in PICU (SD), day | 2.1(0.7) | 10.4 (5.5) |
14 | Sum of patient with empirical antibiotic, n (%) | 15 (83.3%) | 69 (89.6%) |
15 | Sum of patient with definitive antibiotic, n (%) | 5 (27.8%) | 22 (28.6%) |
16 | Mortality, n (%) | 6 (42.9%) | 32 (39.5%) |
17 | The appropriate antibiotic during initiation, n (%) | 12 (85.7%) | 64 (79.0%) |
18 | The appropriate antibiotic during continuation, n (%) | 13 (92.9%) | 54 (66.7%) |
19 | Culture Growth, n (%) | ||
No Growth | 5 (35.7%) | 30 (37.0%) | |
Bacteria | 9 (64.3%) | 51 (63.0%) | |
Fungi | 0 (0%) | 0 (0%) |